INDAPAMIDE WATSON indapamide hemihydrate 2.5mg sugar coated tablet bottle

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

indapamide hemihydrate, Quantity: 2.5 mg

Disponible depuis:

Medis Pharma Pty Ltd

DCI (Dénomination commune internationale):

indapamide hemihydrate

forme pharmaceutique:

Tablet, sugar coated

Composition:

Excipient Ingredients: lactose monohydrate; maize starch; magnesium stearate; povidone; purified talc; calcium carbonate; titanium dioxide; sucrose; Acacia; ethyl acetate; purified water; stearic acid; industrial methylated spirit; polyvinyl acetate phthalate; Shellac; white beeswax; Carnauba Wax

Mode d'administration:

Oral

Unités en paquet:

60 tablets, 90 tablets

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Management of essential hypertension. It may be tried as the sole therapeutic agent in the treatment of mild to moderate hypertension. Normally indapamide is used as the initial agent in multiple drug regimens.

Descriptif du produit:

Visual Identification: White, biconvex, sugar coated tablets.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2012-04-05